Sign in

CIK 0001674416

  • Large accelerated filer

CRISPR Therapeutics AG

Sign in to watch
Ticker
CRSP
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Switzerland
Entity type
Operating
EIN
473173478
Phone
+1 617-315-4600
Business address
BAARERSTRASSE 14, ZUG, Switzerland
Former names
CRISPR Therapeutics AG
  1. 4 Open-market sale Chief Financial Officer sold 3,762 shares at $41.80 ($157,252)
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Open-market sale Chief Executive Officer sold 14,435 shares at an average $42.70 ($616,349)
  6. 4 Open-market sale General Counsel and Secretary sold 3,966 shares at an average $42.67 ($169,242)
  7. 4 Open-market sale Chief Operating Officer sold 1,388 shares at an average $42.54 ($59,050)
  8. 4 Open-market buy Director bought 7,000 shares at $44.85 ($313,948)
  9. 4 Planned sale Chief Executive Officer sold 18,360 shares at $55.21 ($1,013,564)
  10. 4 Open-market sale Chief Operating Officer sold 333 shares at $52.80 ($17,582)
  11. 4 Planned sale Chief Executive Officer sold 18,568 shares at an average $54.21 ($1,006,580)
  12. 4 Open-market sale General Counsel and Secretary sold 11,542 shares at an average $53.67 ($619,492)
  13. 4 Option exercise Chief Executive Officer acquired 13,751 shares (option exercise)
  14. 4 Planned sale Chief Executive Officer sold 15,000 shares at $55.10 ($826,565)
  15. 4 Planned sale Chief Executive Officer sold 30,000 shares at an average $55.62 ($1,668,678)
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 5 of 26 · 502 filings